Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
This study is currently recruiting participants.
Verified May 2011 by Avila Therapeutics
Sponsor:
Avila Therapeutics
Collaborator:
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Avila Therapeutics
ClinicalTrials.gov Identifier:
NCT01351935
First received: May 10, 2011
Last updated: September 7, 2012
Last verified: May 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2014 |
| Estimated Primary Completion Date: | December 2013 (Final data collection date for primary outcome measure) |